Click here to go to the previous page
The Cross-over Between Direct-to-patient Studies, Social Media, and EDC
Program Code:
408
Date:
Thursday, June 28, 2012
Time:
9:00 AM to 10:30 AM
EST
PRESENTER
(S):
An MD by training, with 21 years of experience in the industry. Starting his career in Ciba-Geigy’s group, then started Covance CLS in 1992. He founded PHT Europe office in 2001. PHT develops products facilitating data capture from patients and doctors in clinical trials, using mobile technologies.
|
As President and Director of PatientsLikeMe, Benjamin Heywood is responsible for setting the company vision to improve healthcare and accelerate research, while directing its business growth strategy. Inspired by his brother Stephen’s battle with ALS, Heywood co-founded the company in 2004.
|
Doug Bain, Founder and CEO of eClinicalHealth Ltd,, has been involved in the development, deployment and optimization of eClinical technologies since 1996. eClinicalHealth provides consulting and solution support to life science companies looking for high performance innovation in Clinical R&D.
|
Description
The traditional boundaries between ePRO, Electronic Data Capture (EDC) and community health information sharing are blurring as community principles of social media and direct-to-patient studies emerge. This session examines how Patient Data Capture (PDC) has evolved in recent years, and how this will impact the evolution of data acquisition in clinical trials.
Learning Objectives:
Discuss the current state of social media in clinical R&D
Discuss the value of ePro over paper PRO from regulatory, business, and quality perspectives
Describe the values and challenges of adapting between patient- and site-based data capture Discuss the potential role of social health care in clinical trials.